Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bio-adrenomedullin (Bio-ADM) as a Biomarker of Refilling in Chronic Hemodialysis Patient

NCT05339009 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05339009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05339009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bio-adrenomedullin (Bio-ADM) as a Biomarker of Refilling in Chronic Hemodialysis Patient
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
May 1, 2023
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease 5d